Peptides9 min read
Semaglutide and knee pain: what improved in STEP 9
STEP 9 found better pain and physical-function outcomes in adults with obesity and knee osteoarthritis. Learn why that is different from cartilage repair.
Read articleBlog
Research, explained. Explore peptides, supplements and hormone health with clear, practical breakdowns of what the studies actually tell us.
Peptides articles
All articlesMetabolism, recovery and emerging research
Peptides9 min read
Mazdutide's US phase 2 trial: what a different population adds
The US mazdutide trial broadens the evidence, but actual enrollment, eligibility and small treatment groups define how far its results can travel.
Read article
Peptides9 min read
Higher-dose mazdutide: what the trials tell us about benefit and tolerability
Higher-dose trials show substantial weight reduction, alongside important differences in exposure, analysis methods and gastrointestinal tolerability.
Read article
Peptides9 min read
Petrelintide and amylin: what is actually new?
Petrelintide builds on a familiar fullness hormone with a longer-acting molecule and new formulation possibilities.
Read article
Peptides9 min read
What thymosin beta-4 eye trials tell us—and why they don't validate TB-500 stacks
ARISE-3 and the small corneal-defect trial answer different eye-health questions. Their findings do not establish an injected recovery combination.
Read article
Peptides9 min read
Why KPV is not a diagnosis for persistent digestive symptoms
Persistent digestive symptoms need an explanation. Understand the role of history, targeted tests, symptom tracking and the limits of KPV research.
Read article
Peptides9 min read
Gonadorelin and fertility: the diagnosis determines the role
Why gonadorelin's fertility role depends on the location of the hormone problem, with evidence from male hypogonadism and hypothalamic amenorrhea.
Read article
Peptides8 min read
Bremelanotide trials: what desire and distress scores mean
Understand the separate desire, distress, and satisfying-event results in RECONNECT, including score changes, response thresholds and dropout.
Read article
Peptides9 min read
Ipamorelin's postoperative trial: what the human study actually found
A closer look at ipamorelin's bowel-surgery trial, its nonsignificant meal-tolerance result, serious-event uncertainty and limits for fitness claims.
Read article
Peptides9 min read
Sermorelin versus tesamorelin: shared signaling, different clinical evidence
Sharing the GHRH receptor pathway does not make sermorelin and tesamorelin interchangeable. Their research populations, outcomes, and approved uses differ.
Read article
Peptides8 min read
IGF-1 LR3 is not mecasermin: why the distinction matters
Mecasermin and LR3 share a biological family, but their molecules, clinical uses and supporting evidence are different.
Read article
Peptides8 min read
Glargine versus lente in diabetic cats: what a small trial can tell you
The early comparison tested different insulin schedules. Later studies and current guidance explain why its thirteen completers cannot settle every cat's choice.
Read article73–84 of 320 articles